The special ligand regulation of the FGF19 subfamily allows diverse biological properties of the FGF19 subfamily members but, more importantly, offers a new hope to the treatment of various human metabolic diseases [45,46,47]. This evidence concerns the gene FGF19 and metabolic disease.